Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GABAPENTIN Cause Deep vein thrombosis? 205 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 205 reports of Deep vein thrombosis have been filed in association with GABAPENTIN (Gabapentin). This represents 0.3% of all adverse event reports for GABAPENTIN.

205
Reports of Deep vein thrombosis with GABAPENTIN
0.3%
of all GABAPENTIN reports
28
Deaths
67
Hospitalizations

How Dangerous Is Deep vein thrombosis From GABAPENTIN?

Of the 205 reports, 28 (13.7%) resulted in death, 67 (32.7%) required hospitalization, and 9 (4.4%) were considered life-threatening.

Is Deep vein thrombosis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GABAPENTIN. However, 205 reports have been filed with the FAERS database.

What Other Side Effects Does GABAPENTIN Cause?

Drug ineffective (10,914) Drug hypersensitivity (6,833) Off label use (6,729) Drug ineffective for unapproved indication (5,231) Product use in unapproved indication (4,919) Toxicity to various agents (4,839) Completed suicide (4,111) Dizziness (4,107) Somnolence (3,798) Fatigue (3,791)

What Other Drugs Cause Deep vein thrombosis?

LENALIDOMIDE (3,286) RIVAROXABAN (3,180) TESTOSTERONE (2,213) APIXABAN (1,944) ETHINYL ESTRADIOL\ETONOGESTREL (1,577) RITUXIMAB (1,287) METHOTREXATE (1,146) DROSPIRENONE\ETHINYL ESTRADIOL (1,139) DEXAMETHASONE (1,067) ADALIMUMAB (1,056)

Which GABAPENTIN Alternatives Have Lower Deep vein thrombosis Risk?

GABAPENTIN vs GABAPENTIN ENACARBIL GABAPENTIN vs GADAVIST GABAPENTIN vs GADOBENATE DIMEGLUMINE GABAPENTIN vs GADOBUTROL GABAPENTIN vs GADODIAMIDE

Related Pages

GABAPENTIN Full Profile All Deep vein thrombosis Reports All Drugs Causing Deep vein thrombosis GABAPENTIN Demographics